# Effect of Gabapentin Enacarbil on Opioid Consumption and Pain Scores

> **NCT02840240** · NA · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 107 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Gabapentin enacarbil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02840240
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2018-11-30
- **Final completion:** 2021-04-23
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2024-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02840240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02840240, "Effect of Gabapentin Enacarbil on Opioid Consumption and Pain Scores". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02840240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*